Clinical Trial Update: Olanzapine Versus Comparator in the Treatment of Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing olanzapine against a comparator for bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED